SAS inhibits the glutamate transporter xCT which is an essential oncogene in brain tumors and other tumor entities41,44,53, it shows peritumoral anti-epileptic activity54 and is effective in alleviating tumor-induced brain swelling39. This evidence concerns the gene SLC7A11 and neoplasm.